/term/cost-of-goods-sold-to-revenue/SZSE:002424 Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) COGS-
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Bailing Group Pharmaceutical Co Ltd (SZSE:002424) » Definitions » COGS-to-Revenue

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) COGS-to-Revenue : 0.36 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Guizhou Bailing Group Pharmaceutical Co COGS-to-Revenue?

Guizhou Bailing Group Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥482 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥1,333 Mil.

Guizhou Bailing Group Pharmaceutical Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.36.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Guizhou Bailing Group Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2024 was 63.84%.


Guizhou Bailing Group Pharmaceutical Co COGS-to-Revenue Historical Data

The historical data trend for Guizhou Bailing Group Pharmaceutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhou Bailing Group Pharmaceutical Co COGS-to-Revenue Chart

Guizhou Bailing Group Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.44 0.41 0.40 0.45

Guizhou Bailing Group Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.48 0.45 0.46 0.36

Guizhou Bailing Group Pharmaceutical Co COGS-to-Revenue Calculation

Guizhou Bailing Group Pharmaceutical Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1905.774 / 4262.971
=0.45

Guizhou Bailing Group Pharmaceutical Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=481.911 / 1332.744
=0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guizhou Bailing Group Pharmaceutical Co  (SZSE:002424) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Guizhou Bailing Group Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 481.911 / 1332.744
=63.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Guizhou Bailing Group Pharmaceutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Guizhou Bailing Group Pharmaceutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Business Description

Traded in Other Exchanges
N/A
Address
Economic and Technological Development Zone, Air Boulevard West, Anshun City, CHN, 561000
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company. It is engaged in the production and sale of medicinal tablets, capsules, and syrups.
Executives
Jiang Wei Director
Jiang Yong Directors, executives
Chen Pei Directors, executives
Kuang Xun Hua Director
Niu Min Directors, Directors, and Executives
Chen Zhi Securities Affairs Representative
Zheng Rong Executives
Li Qiang Supervisors
Xia Wen Supervisors
Wang Xiao Dong Supervisors
Teng Chun Jie Supervisors
Li Hui Fang Supervisors
Zhang Jin Fen Director
Cai Shou Xian Executives

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Headlines

No Headlines